选择尺寸
关于此项目
产品名称
18:0 EPC (Cl Salt), Avanti Research™ - A Croda Brand 890703C
InChI
1S/C46H93NO8P.ClH/c1-7-10-12-14-16-18-20-22-24-26-28-30-32-34-36-38-45(48)51-42-44(43-54-56(50,52-9-3)53-41-40-47(4,5)6)55-46(49)39-37-35-33-31-29-27-25-23-21-19-17-15-13-11-8-2;/h44H,7-43H2,1-6H3;1H/q+1;/p-1/t44-,56?;/m1./s1
InChI key
ZVWMOQRUUFNEHD-UFOBXVRVSA-M
SMILES string
O=P(OCC[N+](C)(C)C)(OC[C@]([H])(OC(CCCCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O)OCC.[Cl-]
assay
>99% (TLC)
form
liquid
packaging
pkg of 1 × 2.5 mL (890703C-25mg)
manufacturer/tradename
Avanti Research™ - A Croda Brand 890703C
concentration
10 mg/mL (890703C-25mg)
lipid type
cationic lipids
transfection
shipped in
dry ice
storage temp.
−20°C
Application
- to study its effect on the synergistic antimicrobial action of eugenol against Escherichia coli C600
- to test its use in the formation of lipid nanoparticle variants
- as a constituent of the microbubble formulation
- to prepare lipid monolayer for the study on the nature and orientation of interaction between graphene oxide (GO) and lipid models
Biochem/physiol Actions
Packaging
Legal Information
signalword
Danger
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
target_organs
Central nervous system
wgk
WGK 3
法规信息
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持
